IOL Chemicals and Pharmaceuticals Future Growth
Future criteria checks 4/6
IOL Chemicals and Pharmaceuticals is forecast to grow earnings and revenue by 29.2% and 10.6% per annum respectively. EPS is expected to grow by 29.2% per annum. Return on equity is forecast to be 10.5% in 3 years.
Key information
29.2%
Earnings growth rate
29.2%
EPS growth rate
Pharmaceuticals earnings growth | 17.8% |
Revenue growth rate | 10.6% |
Future return on equity | 10.5% |
Analyst coverage | Low |
Last updated | 21 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 26,731 | 2,168 | N/A | 2,934 | 1 |
3/31/2026 | 24,980 | 1,911 | 39 | 2,280 | 2 |
3/31/2025 | 22,547 | 1,460 | 377 | 1,950 | 2 |
9/30/2024 | 20,524 | 998 | -1,586 | 1,273 | N/A |
6/30/2024 | 20,720 | 1,185 | N/A | N/A | N/A |
3/31/2024 | 21,328 | 1,344 | 159 | 2,901 | N/A |
12/31/2023 | 22,161 | 1,716 | N/A | N/A | N/A |
9/30/2023 | 22,192 | 1,723 | 62 | 2,582 | N/A |
6/30/2023 | 22,153 | 1,503 | N/A | N/A | N/A |
3/31/2023 | 22,171 | 1,391 | -895 | 1,223 | N/A |
12/31/2022 | 22,024 | 1,041 | N/A | N/A | N/A |
9/30/2022 | 22,341 | 1,204 | -538 | 824 | N/A |
6/30/2022 | 22,305 | 1,353 | N/A | N/A | N/A |
3/31/2022 | 21,840 | 1,677 | -602 | 931 | N/A |
12/31/2021 | 20,719 | 2,132 | N/A | N/A | N/A |
9/30/2021 | 20,298 | 2,879 | 703 | 2,228 | N/A |
6/30/2021 | 20,254 | 3,840 | N/A | N/A | N/A |
3/31/2021 | 19,670 | 4,446 | 2,716 | 3,798 | N/A |
12/31/2020 | 19,481 | 4,596 | N/A | N/A | N/A |
9/30/2020 | 19,463 | 4,428 | 2,902 | 3,779 | N/A |
6/30/2020 | 18,618 | 4,035 | N/A | N/A | N/A |
3/31/2020 | 18,945 | 3,613 | 3,905 | 4,708 | N/A |
12/31/2019 | 18,753 | 3,727 | N/A | N/A | N/A |
9/30/2019 | 18,423 | 3,569 | N/A | N/A | N/A |
6/30/2019 | 18,163 | 3,076 | N/A | N/A | N/A |
3/31/2019 | 16,853 | 2,367 | 2,126 | 2,732 | N/A |
12/31/2018 | 15,506 | 1,465 | N/A | N/A | N/A |
9/30/2018 | 13,350 | 731 | N/A | N/A | N/A |
6/30/2018 | 11,298 | 391 | N/A | N/A | N/A |
3/31/2018 | 9,833 | 277 | N/A | 1,197 | N/A |
12/31/2017 | 8,891 | 178 | N/A | N/A | N/A |
9/30/2017 | 8,094 | 100 | N/A | N/A | N/A |
6/30/2017 | 8,265 | 65 | N/A | N/A | N/A |
3/31/2017 | 7,107 | 47 | N/A | 833 | N/A |
12/31/2016 | 6,595 | 39 | N/A | N/A | N/A |
9/30/2016 | 6,197 | -74 | N/A | N/A | N/A |
6/30/2016 | 6,055 | -214 | N/A | N/A | N/A |
3/31/2016 | 5,804 | -400 | N/A | 177 | N/A |
12/31/2015 | 5,131 | -692 | N/A | N/A | N/A |
9/30/2015 | 4,377 | -890 | N/A | N/A | N/A |
6/30/2015 | 4,008 | -858 | N/A | N/A | N/A |
3/31/2015 | 3,847 | -667 | N/A | -470 | N/A |
12/31/2014 | 4,405 | -378 | N/A | N/A | N/A |
9/30/2014 | 5,115 | -71 | N/A | N/A | N/A |
6/30/2014 | 5,452 | 37 | N/A | N/A | N/A |
3/31/2014 | 5,635 | 33 | N/A | 784 | N/A |
12/31/2013 | 5,684 | 26 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 524164's forecast earnings growth (29.2% per year) is above the savings rate (6.7%).
Earnings vs Market: 524164's earnings (29.2% per year) are forecast to grow faster than the Indian market (17.9% per year).
High Growth Earnings: 524164's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 524164's revenue (10.6% per year) is forecast to grow faster than the Indian market (10.4% per year).
High Growth Revenue: 524164's revenue (10.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 524164's Return on Equity is forecast to be low in 3 years time (10.5%).